Clinical Trial Update: Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update compares PEG-400 based artificial tears with Systane in a bilateral, masked study for treating dry eye signs, symptoms, and v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• PEG-400 based artificial tear (polyethylene glycol-based artificial tear)
• Systane

Snippet

Sponsor: Bp Consulting, Inc | Conditions: Dry Eye | Phase 4 | Status: COMPLETED